UNITY Biotechnology to Participate in the Cowen 42nd Annual Health Care Conference

Rhea-AI Summary

UNITY Biotechnology (NASDAQ: UBX) will present a corporate update at the Cowen 42nd Annual Health Care Conference on March 7, 2022, at 11:10 a.m. ET. The event will be virtual, and a replay will be accessible for 90 days afterward. UNITY focuses on developing therapeutics aimed at slowing, halting, or reversing diseases associated with aging, particularly in age-related ophthalmologic and neurologic conditions. Interested investors can access the presentation through the Cowen conference portal or their website.

SOUTH SAN FRANCISCO, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that members of its senior management team will provide a corporate update and participate in one-on-one investor meetings at the Cowen 42nd Annual Health Care Conference taking place virtually on Monday, March 7, 2022, at 11:10 a.m. ET.

The presentation will be available through the Cowen conference portal and will also be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.

About UNITY

UNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.

Media Contact
Canale Communications
Jason Spark
Jason.spark@canalecomm.com

Investor Contact
LifeSci Advisors, LLC
Joyce Allaire
jallaire@lifesciadvisors.com

FAQ

What is the date and time of UNITY's presentation at the Cowen 42nd Annual Health Care Conference?

UNITY's presentation is scheduled for March 7, 2022, at 11:10 a.m. ET.

Where can I watch the replay of UNITY's Cowen conference presentation?

The replay of UNITY's presentation will be available for 90 days on the Cowen conference portal and the Investors & Media section of UNITY's website.

What is the focus of UNITY Biotechnology in their therapeutics development?

UNITY focuses on developing therapeutics that slow, halt, or reverse diseases of aging, particularly in ophthalmologic and neurologic conditions.

What is the stock symbol for UNITY Biotechnology?

The stock symbol for UNITY Biotechnology is UBX.

How can investors get updates from UNITY Biotechnology?

Investors can get updates from UNITY Biotechnology through their website and social media channels like Twitter and LinkedIn.